Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MBRP With or Without Vortioxetine for Methamphetamine Relapse Prevention
NCT03830827Phase 4Unknown
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Sep 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of vortioxetine in methamphetamine use disorder (MUD), sponsored by Sir Run-Run Shaw Hospital. Status: unknown.
02
Drugs
vortioxetine
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT03830827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03830827.